Boston Scientific Other Operating Income or Expenses 2010-2024 | BSX

Boston Scientific annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Boston Scientific other operating income or expenses for the quarter ending September 30, 2024 were $0.023B, a 76.53% decline year-over-year.
  • Boston Scientific other operating income or expenses for the twelve months ending September 30, 2024 were $-0.287B, a 160.91% increase year-over-year.
  • Boston Scientific annual other operating income or expenses for 2023 were $-0.005B, a 98.62% decline from 2022.
  • Boston Scientific annual other operating income or expenses for 2022 were $-0.362B, a 38.23% decline from 2021.
  • Boston Scientific annual other operating income or expenses for 2021 were $-0.586B, a 8.15% decline from 2020.
Boston Scientific Annual Other Operating Income or Expenses
(Millions of US $)
2023 $-5
2022 $-362
2021 $-586
2020 $-638
2019 $-185
2018 $-117
2017 $-209
2016 $-844
2015 $-1,247
2014 $-1,134
2013 $-442
2012 $-313
2011 $702
2010 $37
2009 $-2,034
Boston Scientific Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-09-30 $23
2024-06-30 $-278
2024-03-31 $-17
2023-12-31 $-15
2023-09-30 $98
2023-06-30 $-76
2023-03-31 $-12
2022-12-31 $-120
2022-09-30 $-145
2022-06-30 $-85
2022-03-31 $-12
2021-12-31 $-276
2021-09-30 $-62
2021-06-30 $-256
2021-03-31 $8
2020-12-31 $-29
2020-09-30 $-485
2020-06-30 $-34
2020-03-31 $-90
2019-12-31 $-199
2019-09-30 $-33
2019-06-30 $-62
2019-03-31 $109
2018-12-31 $-76
2018-09-30 $-5
2018-06-30 $-30
2018-03-31 $-6
2017-12-31 $-88
2017-09-30 $13
2017-06-30 $-181
2017-03-31 $47
2016-12-31 $-171
2016-09-30 $-8
2016-06-30 $-651
2016-03-31 $-14
2015-12-31 $-493
2015-09-30 $-507
2015-06-30 $-27
2015-03-31 $-220
2014-12-31 $-688
2014-09-30 $-151
2014-06-30 $-281
2014-03-31 $-14
2013-12-31 $-241
2013-09-30 $-99
2013-06-30 $-1
2013-03-31 $-101
2012-12-31 $-72
2012-09-30 $-32
2012-06-30 $-199
2012-03-31 $-10
2011-12-31 $10
2011-09-30 $-7
2011-06-30 $-55
2011-03-31 $754
2010-12-31 $286
2010-09-30 $-5
2010-06-30 $-54
2010-03-31 $-190
2009-12-31 $-1,483
2009-09-30 $-254
2009-06-30 $-10
2009-03-31 $-287
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $132.644B $14.240B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.249B 26.05
Stryker (SYK) United States $146.711B 33.06
EssilorLuxottica (ESLOY) France $112.106B 0.00
Medtronic (MDT) Ireland $110.562B 16.42
Haleon (HLN) United Kingdom $43.682B 28.38
Lonza Group Ag (LZAGY) Switzerland $42.166B 0.00
GE HealthCare Technologies (GEHC) United States $37.665B 19.54
ResMed (RMD) United States $35.786B 29.41
Terumo (TRUMY) Japan $29.739B 0.00
Koninklijke Philips (PHG) Netherlands $24.805B 18.99
Zimmer Biomet Holdings (ZBH) United States $21.942B 13.97
Insulet (PODD) United States $18.443B 73.44
Baxter (BAX) United States $16.957B 11.03
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.158B 40.72
Bio-Rad Laboratories (BIO) United States $9.320B 31.68
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.294B 14.62
TG Therapeutics (TGTX) United States $5.459B 0.00
Haemonetics (HAE) United States $4.297B 20.97
Prestige Consumer Healthcare (PBH) United States $4.192B 20.85
ICU Medical (ICUI) United States $4.125B 39.27
Perrigo (PRGO) Ireland $3.830B 11.27
Envista Holdings (NVST) United States $3.697B 27.54
Neogen (NEOG) United States $3.246B 37.45
Agios Pharmaceuticals (AGIO) United States $3.175B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.841B 18.22
QuidelOrtho (QDEL) United States $2.700B 17.38
LeMaitre Vascular (LMAT) United States $2.428B 59.00
Warby Parker (WRBY) United States $2.349B 0.00
Green Thumb Industries (GTBIF) United States $1.913B 33.48
AtriCure (ATRC) United States $1.742B 0.00
InMode (INMD) Israel $1.597B 9.61
AdaptHealth (AHCO) United States $1.326B 9.48
Maravai LifeSciences Holdings (MRVI) United States $1.318B 0.00
Curaleaf Holdings (CURLF) Canada $1.267B 0.00
BioLife Solutions (BLFS) United States $1.207B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.952B 7.44
CeriBell (CBLL) United States $0.943B 0.00
National Vision Holdings (EYE) United States $0.918B 30.68
Capricor Therapeutics (CAPR) United States $0.847B 0.00
Evolus (EOLS) United States $0.798B 0.00
VAREX IMAGING (VREX) United States $0.684B 30.25
Omeros (OMER) United States $0.632B 0.00
Surmodics (SRDX) United States $0.563B 0.00
Cresco Labs (CRLBF) United States $0.533B 0.00
Verano Holdings (VRNOF) United States $0.522B 0.00
Canopy Growth (CGC) Canada $0.468B 0.00
Quanterix (QTRX) United States $0.451B 0.00
ZimVie (ZIMV) United States $0.391B 32.95
Valneva SE (VALN) France $0.360B 0.00
Viemed Healthcare (VMD) United States $0.341B 32.41
Cerus (CERS) United States $0.332B 0.00
Sanara MedTech (SMTI) United States $0.330B 0.00
Biote (BTMD) United States $0.325B 7.12
OraSure Technologies (OSUR) United States $0.289B 19.40
Zynex (ZYXI) United States $0.263B 55.07
Aurora Cannabis (ACB) Canada $0.238B 0.00
TerrAscend (TSNDF) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.221B 15.29
High Tide (HITI) Canada $0.213B 88.33
MacroGenics (MGNX) United States $0.203B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.167B 100.00
Organigram Holdings (OGI) Canada $0.166B 0.00
Jin Medical (ZJYL) China $0.164B 0.00
Zevia PBC (ZVIA) United States $0.160B 0.00
FitLife Brands (FTLF) United States $0.149B 18.67
TriSalus Life Sciences (TLSI) United States $0.138B 0.00
Fonar (FONR) United States $0.104B 11.74
Quipt Home Medical (QIPT) United States $0.104B 0.00
Veru (VERU) United States $0.099B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.40
Ayr Wellness (AYRWF) United States $0.077B 0.00
Rockwell Medical (RMTI) United States $0.073B 37.50
Exagen (XGN) United States $0.072B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.062B 0.00
Modular Medical (MODD) United States $0.058B 0.00
MariMed (MRMD) United States $0.057B 0.00
Apyx Medical (APYX) United States $0.054B 0.00
Safety Shot (SHOT) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
Meihua Medical Technologies (MHUA) China $0.018B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00